Last updated on September 2019

Protocol AR19.004 - Multicenter, Fixed-Dose, Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of AR19 (Amphetamine Sulfate) in Adult Subjects (Ages 18-55) with Attention Deficit Hyperactivity Disorder (ADHD)

Brief description of study

AR19 versus placebo in Adult ADHD.


Clinical Study Identifier: TX216178

Find a site near you

Start Over

Pharmacology Research Institute, Encino

6345 Balboa Blvd., Building III, Suite 363 Encino, CA United States
  Connect »